Osteoporosis drug effective in preventing breast cancer.
D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*
D016588:Anticarcinogenic Agents; D050071:Bone Density Conservation Agents; D020849:Raloxifene Hydrochloride